Separation Systems for Commercial Biotechnology Market

Separation Systems for Commercial Biotechnology Market - Snapshot

Commercial biotechnology separation system helps in bioseparation. Bioseparation purifies biological products such as biochemical, diagnostic reagents, and biopharmaceuticals. Bioseparation depends on several factors such as density, charge, shape, polarity, diffusivity, volatility, and solubility.

At present liquid chromatography is one of leading bioseparation techniques used. As a result of advancement, the technique is expected to contribute substantially to growth of the market.

The separation system for commercial biotechnology market is anticipated to grow in the coming years. Growth of the market is attributed to various factors such as financial aid by government bodies in several countries, technological advancements in the field, execution of high-tech strategies, and introduction of new techniques. Surge in demand for cell-based therapies and personalized medicines are also contributing to the growth of separation system for commercial biotechnology market.

As per market analysts, DNA microarray is one of the prominent segments in separation system for commercial biotechnology market. The segment is projected to contribute enormously to the global separation system commercial market. 

At present, two-third of world population consists of elderly people. The percentage of geriatric population is anticipated to increase significantly in coming years due to decreased mortality rate and fertility rate. Increasing geriatric population is likely to push the demand for biopharmaceuticals market. This, in turn, is expected to boost the global system commercial biotechnology market.

Further, technological advancements in the separation system for commercial biotechnology are ongoing. Accurate cell and molecule sorting technique is used in wide range of applications in numerous industries. Technologically advanced upstream processing is one technology that is enabling elimination of bio-hazardous byproducts, simplifying procedures, and reducing equipment size.

Huge investment inflow is facilitating research and development activities in the field. Some of the innovations are flow cytometer and membrane filtration systems. Further, ongoing development activities are likely to fuel growth of the separation system for commercial biotechnology market in coming years.

Global Separation Systems for Commercial Biotechnology Market: Snapshot

The global separation systems for commercial biotechnology market has been growing at a healthy pace in the last few years. The rising number of biotech companies and the increasing investments in the research and development activities are projected to encourage the growth of the overall market in the next few years.

According to the market research study that has been recently published by Transparency Market Research, the global market for separation systems for commercial biotechnology is projected to reach a value of US$19,227.8 mn by the end of year 2023. The market is predicted to register a promising growth rate in the next few years.

Rising Research and Development Activities to Encourage Market Growth

In the last few years the chromatography systems have gained immense popularity, thanks to the introduction of new technologies in chromatographic consumables and instruments, which is predicted to encourage the growth of the global separation systems for commercial biotechnology market in the next few years. The rapid development of the flow cytometry has emerged as a leading technology, which is projected to enhance the market growth in the next few years. In addition to this, the growing demand and the advancements in the microarray technology is another major factor that is predicted to accelerate the growth of the market in the near future.

On the flip side, the high cost of technologies and systems and the patent rights over MACS technique are some of the key factors that are predicted to hamper the growth of the global separation systems for commercial biotechnology market in the next few years. Moreover, the lack of innovations in the electrophoresis equipment technology is likely to restrict the market growth in the near future. Nonetheless, the rising awareness among consumers regarding the chromatography has induced the government organizations in Asia Pacific, Europe, and the U.S. to increase their funds, grants, and investments, which is projected to accelerate the growth of the overall market in the next few years.

North America to Dominate Global Separation Systems for Commercial Biotechnology Market?

The global market for separation systems for commercial biotechnology has been classified on the basis of geography into Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa. Previously, North America held a large share of the market and registered a healthy growth rate. This region is projected to remain in the top position in the next few years. The high growth of this region can be attributed to the presence of several leading players and the growing focus on the research and development activities. Europe is projected to stand on the second position further followed by Asia Pacific. Technological advancements and the growing use of other imaging technologies is projected to encourage the growth of this region in the next few years.

The global market for separation systems for commercial biotechnology is considered as a highly competitive market with a huge number of players operating across the globe. The key players in the market are focusing on the development of new products in order to stay ahead of the rivals and attract a large number of consumers in the next few years. In addition to this, the growing focus of the key players on the research and development activities is projected to support the growth of the market and generate potential development prospects for the market players in the next few years. Some of the key players operating in the separation systems for commercial biotechnology market across the globe are Danaher Corporation, Thermo Fisher Scientific, Inc., Merck KGaA, Waters Corporation, Becton, Dickinson and Company, and GE Healthcare.